TP53 and neoplasm: To exclude involvement of a major tumor suppressor in mediating DKK3‐associated effects, we assessed p53 activity in tumor cells: neither p53 phosphorylation nor the expression of its downstream targets changed during tumor progression in KC or DDKC models, arguing against p53 loss (Figure 1P–T; Figure S1N, Supporting Information).